Track Precipio, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Precipio, Inc. PRPO · Stock Open Precipio, Inc. in new tab

26.54 USD
Add to portfolio
EPS
-0.62
P/B
3.21
ROE
-8.98
Beta
1.33
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateNov. 16, 2026
EPS-0.62
Book Value8.25
Price to Book3.21
Debt/Equity24.31
% Insiders12.630%
Growth
Revenue Growth0.24%
Estimates
Forward P/E67.85
Forward EPS0.39

DCF Valuation

Tweak assumptions to recompute fair value for Precipio, Inc. (PRPO)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Precipio, Inc. Logo Precipio, Inc. Analysis (PRPO)

United States Health Care Official Website Stock

Is Precipio, Inc. a good investment? Precipio, Inc. (PRPO) is currently trading at 26.54 USD.

Earnings Schedule: Precipio, Inc. is expected to release its next earnings report on Nov. 16, 2026. The market consensus estimate for Forward EPS is 0.39.

Investor FAQ

Does Precipio, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Precipio, Inc.?

Precipio, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Nov. 16, 2026. The company currently has a trailing EPS of -0.62.

Company Profile

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.

Exchange Ticker
NMS (United States) PRPO
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
April 29, 2019 0.07
Sept. 22, 2023 1:20
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion